{"ORPHApacket":[{"ORPHApacketID":"85453","date":"2019-12-05 19:03:59","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"85453","Name":[{"lang":"en","label":"X-linked reticulate pigmentary disorder"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_85453","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Syndromic corneal dystrophy"}],"ORPHA":"98628","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98628"},{"Name":[{"lang":"en","label":"Genetic hyperpigmentation of the skin"}],"ORPHA":"183466","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_183466"},{"Name":[{"lang":"en","label":"Type 1 interferonopathy"}],"ORPHA":"477647","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_477647"},{"Name":[{"lang":"en","label":"Immune dysregulation disease with immunodeficiency"}],"ORPHA":"169361","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_169361"},{"Name":[{"lang":"en","label":"Rare systemic disease"}],"ORPHA":"182222","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_182222"},{"Name":[{"lang":"en","label":"Type 1 interferonopathy of childhood"}],"ORPHA":"481671","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_481671"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"X-linked reticulate pigmentary disorder is an extremely rare skin disease described in only four families to date and characterized in males by diffuse reticulate brown hyperpigmentated skin lesions developing in early childhood and a variety of systemic manifestations (recurrent pneumonia, corneal opacification, gastrointestinal inflammation, urethral stricture, failure to thrive, hypohidrosis, digital clubbing, and unruly hair and flared eyebrows), while in females, there is only cutaneous involvement with the development in early childhood of localized brown hyperpigmented skin lesions following the lines of Blaschko. This disease was first considered as a cutaneous amyloidosis, but amyloid deposits are an inconstant feature."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"301220","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"X-linked dominant"}]}]}],"SynonymList":[{"count":"5","Synonym":[{"lang":"en","label":"Familial cutaneous amyloidosis"},{"lang":"en","label":"PDR"},{"lang":"en","label":"Partington disease"},{"lang":"en","label":"X-linked cutaneous amyloidosis"},{"lang":"en","label":"XLPDR"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"DNA polymerase alpha 1, catalytic subunit"}],"Symbol":"POLA1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"9173"},{"Source":"OMIM","Reference":"312040"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"410295","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) (loss of function) in"}]}]}]}]}]}